Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods
- 1 June 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 119 (6), 1231-1237
- https://doi.org/10.1016/s0002-8703(05)80169-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Multicenter trial of intravenous Anisoylated Plasminogen Streptokinase Activator Complex (APSAC) in acute myocardial infarction: Effects on infarct size and left, ventricular functionJournal of the American College of Cardiology, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.Circulation, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum α-hydroxybutyrate dehydrogenase levelsAmerican Heart Journal, 1984